STAA vs. QDEL, NEOG, CERS, OSUR, ANIK, UTMD, COO, WST, ALGN, and MMSI
Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include QuidelOrtho (QDEL), Neogen (NEOG), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), and Merit Medical Systems (MMSI). These companies are all part of the "health care supplies" industry.
STAAR Surgical vs.
QuidelOrtho (NASDAQ:QDEL) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.
QuidelOrtho presently has a consensus target price of $51.20, indicating a potential upside of 26.54%. STAAR Surgical has a consensus target price of $26.86, indicating a potential upside of 59.20%. Given STAAR Surgical's higher possible upside, analysts plainly believe STAAR Surgical is more favorable than QuidelOrtho.
STAAR Surgical has lower revenue, but higher earnings than QuidelOrtho. STAAR Surgical is trading at a lower price-to-earnings ratio than QuidelOrtho, indicating that it is currently the more affordable of the two stocks.
QuidelOrtho received 157 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 67.07% of users gave QuidelOrtho an outperform vote while only 54.43% of users gave STAAR Surgical an outperform vote.
QuidelOrtho has a beta of 0.08, suggesting that its stock price is 92% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.
99.0% of QuidelOrtho shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 1.0% of QuidelOrtho shares are held by insiders. Comparatively, 1.0% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, STAAR Surgical had 1 more articles in the media than QuidelOrtho. MarketBeat recorded 13 mentions for STAAR Surgical and 12 mentions for QuidelOrtho. QuidelOrtho's average media sentiment score of 0.54 beat STAAR Surgical's score of 0.22 indicating that QuidelOrtho is being referred to more favorably in the media.
STAAR Surgical has a net margin of -6.44% compared to QuidelOrtho's net margin of -72.84%. QuidelOrtho's return on equity of 3.78% beat STAAR Surgical's return on equity.
Summary
QuidelOrtho beats STAAR Surgical on 10 of the 17 factors compared between the two stocks.
Get STAAR Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
STAAR Surgical Competitors List
Related Companies and Tools
This page (NASDAQ:STAA) was last updated on 2/22/2025 by MarketBeat.com Staff
Free STAA Stock Alerts